Holdings
Lion Point Capital, LP
As of Jun 30, 2026, Lion Point Capital, LP reported 30 positions worth US$16.3M. Largest: Cue Biopharma, Inc., Praxis Precision Medicines, Inc. and Fennec Pharmaceuticals Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cue Biopharma, Inc. | 52,928 | US$1.67M | new | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 4,450 | US$1.49M | no change | Jun 30, 2026 |
| Fennec Pharmaceuticals Inc. | 112K | US$1.21M | no change | Jun 30, 2026 |
| Milestone Pharmaceuticals Inc. | 820K | US$1.1M | no change | Jun 30, 2026 |
| Benitec Biopharma Inc. | 62,000 | US$830K | no change | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 36,000 | US$787K | no change | Jun 30, 2026 |
| Biohaven Ltd. | 51,700 | US$769K | no change | Jun 30, 2026 |
| Geron Corporation | 578K | US$740K | no change | Jun 30, 2026 |
| Ardelyx, Inc. | 129K | US$656K | no change | Jun 30, 2026 |
| Lantheus Holdings, Inc. | 5,500 | US$610K | no change | Jun 30, 2026 |